|
|
Quarterly Results |
|
Fermenta Biotech Ltd | Industry : Pharmaceuticals - Indian - Bulk Drugs | Chairman : Pradeep Manjunath Chandan | Home : Indian Private | Book Value: 105.2575279 | BSE Code : 506414 | Market Cap: 519.75 | NSE Code : | P / E : 57.34 | |
| |
|
|
|
|
|
(Rs in Cr.) |
|
Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | Net Sales | 89.35 | 51.31 | 76.78 | 100.59 | Other Income | 2.58 | 2.03 | 2.05 | 1.07 | Total Income | 91.93 | 53.33 | 78.83 | 101.66 | Total Expenditure | 62.86 | 71.93 | 63.59 | 90.24 | Operating Profit | 29.07 | -18.59 | 15.24 | 11.42 | Interest | 5.16 | 3.72 | 4.76 | 6.31 | Gross Profit | 23.91 | -22.31 | 10.48 | 5.11 | Depreciation | 6.13 | 5.68 | 5.69 | 5.88 | Tax | 6.08 | 0.00 | 0.00 | 1.33 | Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | Reported Profit After Tax | 11.70 | -27.98 | 4.79 | -2.11 |
|
|
|
|
|